Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 137.3 SEK -2.21% Market Closed
Market Cap: 18.6B SEK

Wall Street
Price Targets

VITR Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VITR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VITR is 230.69 SEK with a low forecast of 161.6 SEK and a high forecast of 273 SEK.

Lowest
Price Target
161.6 SEK
18% Upside
Average
Price Target
230.69 SEK
68% Upside
Highest
Price Target
273 SEK
99% Upside
Vitrolife AB Competitors:
Price Targets
INSM
Insmed Inc
0% Downside
BSLN
Basilea Pharmaceutica AG
80% Upside
DTIL
Precision BioSciences Inc
367% Upside
ARGX
argenx SE
46% Upside
214450
PharmaResearch Co Ltd
4% Downside
FHTX
Foghorn Therapeutics Inc.
127% Upside
300009
Anhui Anke Biotechnology Group Co Ltd
32% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
53% Upside

Revenue
Forecast

Revenue Estimate
Vitrolife AB

For the last 8 years the compound annual growth rate for Vitrolife AB's revenue is 20%. The projected CAGR for the next 3 years is 7%.

20%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vitrolife AB

For the last 8 years the compound annual growth rate for Vitrolife AB's operating income is 16%. The projected CAGR for the next 3 years is 12%.

16%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Vitrolife AB

For the last 8 years the compound annual growth rate for Vitrolife AB's net income is 13%. The projected CAGR for the next 3 years is 19%.

13%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VITR's stock price target?
Price Target
230.69 SEK

According to Wall Street analysts, the average 1-year price target for VITR is 230.69 SEK with a low forecast of 161.6 SEK and a high forecast of 273 SEK.

What is Vitrolife AB's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Vitrolife AB's revenue is 20%. The projected CAGR for the next 3 years is 7%.

What is Vitrolife AB's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Vitrolife AB's operating income is 16%. The projected CAGR for the next 3 years is 12%.

What is Vitrolife AB's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Vitrolife AB's net income is 13%. The projected CAGR for the next 3 years is 19%.

Back to Top